Abstract
Purpose
To evaluate the outcome of transjugular intrahepatic portosystemic shunt (TIPS) in patients with Budd–Chiari syndrome (BCS).
Patients and Methods
Fourteen patients (11 female, mean age 45.8 years), with symptomatic BCS refractory to conventional therapy, were treated with TIPS placement in our department within a period of 9 years. Stent grafts were primarily used in 12 patients. Mean follow-up time was 38.1 ± 36.1 months (range 7–114). Model for end-stage liver disease (MELD) score, BCS Rotterdam index, and Child–Pugh score were calculated for all patients. In addition, the recently suggested BCS–TIPS prognostic index score (BSC–TIPS PI) was applied.
Results
BCS–TIPS PI score was ≤7 in all patients. Most of our patients (12 of 14) had good or intermediate prognosis according to MELD, Rotterdam and Child–Pugh scores. Technical success was achieved in all 14 patients and was accompanied by complete resolution of the symptoms. In 3 patients, the procedure was complicated by hemoperitoneum, which was successfully treated in two patients with coils or stent-graft placement, whereas 1 patient was managed in the operating room. Thirteen patients are symptom and orthotopic liver transplantation–free. Primary patency was 92.8, 84.7, and 58.7 % at 6, 12, and 24 months, respectively. Secondary patency was 100, 100 and 84.6 % at 6, 12, and 24 months respectively.
Conclusion
In symptomatic BCS patients with moderate prognosis according to MELD, Child–Pugh, and BCS Rotterdam scores, as well as BCS–TIPS PI score ≤7, TIPS has high clinical success, low morbidity, and no mortality, and it offers durable mid-term resolution of the symptoms and OLT-free survival.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Janssen HL, Garcia-Pagan JC, Elias E et al (2003) Budd–Chiari syndrome: a review by an expert panel. J Hepatol 38:364–371
Hadengue A, Poliquin M, Vilgrain V et al (1994) The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 106:1042–1047
Menon KV, Shah V, Kamath PS (2004) The Budd–Chiari syndrome. N Engl J Med 350:578–585
Valla DC (2009) Primary Budd–Chiari syndrome. J Hepatol 50:195–203
Plessier A, Sibert A, Consigny Y et al (2006) Aiming at minimal invasiveness as a therapeutic strategy for Budd–Chiari syndrome. Hepatology 44:1308–1316
Perello A, Garcia-Pagan JC, Gilabert R et al (2002) TIPS Is a useful long-term derivative therapy for patients with Budd–Chiari syndrome uncontrolled by medical therapy. Hepatology 35:132–139
Mancusco A, Fung K, Mela M, Tibballs J et al (2003) TIPS for acute and chronic Budd–Chiari syndrome: a single-centre experience. J Hepatol 38:751–754
Rossle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D (2004) The Budd–Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 135:394–403
Kavanagh PM, Roberts J, Gibney R, Malone D, Hegarty J, McGormick PA (2004) Acute Budd–Chiari syndrome with liver failure: the experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 19:1135–1139
Hernandez-Guerra M, Turnes J, Rubinstein P et al (2004) PTFE covered stents improve TIPS patency in Budd–Chiari syndrome. Hepatology 40:1197–1202
Gandini R, Konda D, Simonetti G (2006) Transjugular intrahepatic portosystemic shunt patency and clinical outcome in patients with Budd–Chiari syndrome: covered versus uncovered stents. Radiology 241:298–305
Garcia-Pagan JC, Heydtmann M, Raffa S et al (2008) TIPS for Budd–Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 135:808–815
de Franchis R (2005) Evolving consensus in portal hypertension report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43:167–176
Bilbao JI, Elorz M, Vivas I, Martνnez-Cuesta A, Bastarrika G, Benito A (2004) Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients. Cardiovasc Intervent Radiol 27:474–480
Murad SD, Valla DC, de Groen PC et al (2004) Determinants of survival and the effect of portosystemic shunting in patients with Budd–Chiari syndrome. Hepatology 39:500–508
Malinchoc M, Kamath PS, Gordon FD et al (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864–871
Pugh RN, Murray-Lyon MI, Dwason LJ et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649
Zeitoun G, Escolano S, Hadengue A et al (1999) Outcome of Budd–Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 30:84–89
Conflict of Interest
The authors have no conflict of interest. There are no potential benefits in any form from a commercial party related directly or indirectly to the manuscript subject to be declared by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fitsiori, K., Tsitskari, M., Kelekis, A. et al. Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Budd–Chiari Syndrome Patients: Results From a Single Center. Cardiovasc Intervent Radiol 37, 691–697 (2014). https://doi.org/10.1007/s00270-013-0697-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-013-0697-9